Basic Information
RNALocate ID: | RLID-D:11001582 |
RNA Symbol: | hsa-miR-411-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-411-3p |
RNA ID: | miRBase:MIMAT0004813 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11004052 | Exosome | Plasma | 23663360 |
RLID:11004053 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID-D:11000707 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-411-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-48083 |
MNDR | hsa-miR-411-3p | Oral squamous cell carcinoma | MNDR-E-MI-48084 |
MNDR | hsa-miR-411-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-48085 |
MNDR | hsa-miR-411-3p | Lymphoma | MNDR-E-MI-48086 |
MNDR | hsa-miR-411-3p | Prostate cancer | MNDR-E-MI-48087 |
MNDR | hsa-miR-411-3p | Alzheimer disease | MNDR-E-MI-48088 |
MNDR | hsa-miR-411-3p | Cardiovascular disease | MNDR-E-MI-48089 |
MNDR | hsa-miR-411-3p | Parkinson disease | MNDR-E-MI-48090 |
MNDR | hsa-miR-411-3p | Breast cancer | MNDR-E-MI-48091 |
MNDR | hsa-miR-411-3p | Pituitary neoplasms | MNDR-E-MI-48092 |
MNDR | hsa-miR-411-3p | Pancreatic cancer | MNDR-E-MI-48093 |
MNDR | hsa-miR-411-3p | Rectum adenocarcinoma | MNDR-E-MI-48094 |
MNDR | hsa-miR-411-3p | Colon cancer | MNDR-E-MI-48095 |
MNDR | hsa-miR-411-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-48096 |
MNDR | hsa-miR-411-3p | Familial ovarian cancer | MNDR-E-MI-48097 |
MNDR | hsa-miR-411-3p | Prostate adenocarcinoma | MNDR-E-MI-48098 |
MNDR | hsa-miR-411-3p | Carcinoma ductal breast | MNDR-E-MI-48099 |
MNDR | hsa-miR-411-3p | Glioblastoma | MNDR-E-MI-48100 |
MNDR | hsa-miR-411-3p | Osteosarcoma | MNDR-E-MI-48101 |
MNDR | hsa-miR-411-3p | Gastric adenocarcinoma | MNDR-E-MI-48102 |
MNDR | hsa-miR-411-3p | Cervical squamous cell carcinoma | MNDR-E-MI-48103 |
MNDR | hsa-miR-411-3p | Pituitary adenoma | MNDR-E-MI-48104 |
MNDR | hsa-miR-411-3p | Lung adenocarcinoma | MNDR-E-MI-48105 |
MNDR | hsa-miR-411-3p | Adrenocortical carcinoma | MNDR-E-MI-48106 |
MNDR | hsa-miR-411-3p | Bladder urothelial carcinoma | MNDR-E-MI-48107 |
MNDR | hsa-miR-411-3p | Pancreatic adenocarcinoma | MNDR-E-MI-48108 |
MNDR | hsa-miR-411-3p | Cholangiocarcinoma | MNDR-E-MI-48109 |
MNDR | hsa-miR-411-3p | Synovial sarcoma | MNDR-E-MI-48110 |
MNDR | hsa-miR-411-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-48111 |
MNDR | hsa-miR-411-3p | Breast invasive carcinoma | MNDR-E-MI-48112 |
MNDR | hsa-miR-411-3p | Hepatocellular carcinoma | MNDR-E-MI-48113 |
MNDR | hsa-miR-411-3p | Familiar ovarian carcinoma | MNDR-E-MI-48114 |
MNDR | hsa-miR-411-3p | Crohn disease | MNDR-E-MI-48115 |
TOP